CNTB CONNECT BIOPHARMA HLDGS LTD
FollowSHS (common), issuer CIK 1835268
15 managers (15 13F filers) reported a position in CNTB shares at 2025-09-30, 1,621,133 shares in all. 15 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 15
- 13F filers
- 15
- New
- 15
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 1,621,133
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- BML Investment Partners, L.P. (group BML Investment Partners, L.P.)
4,264,400 shares, 6.77% in a 13G as of 2026-09-30,0001373604-26-000057
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2025
Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
BML Investment Partners, L.P. and 1 other reporting person reported 4,264,400 CNTB shares, 6.77% of the class, as of 2026-09-30, in a 13G filed 2026-10-06. 0001373604-26-000057
Accepted , ingested